These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38046278)

  • 41. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
    Liu M; Zhou J; Liu X; Feng Y; Yang W; Wu F; Cheung OK; Sun H; Zeng X; Tang W; Mok MTS; Wong J; Yeung PC; Lai PBS; Chen Z; Jin H; Chen J; Chan SL; Chan AWH; To KF; Sung JJY; Chen M; Cheng AS
    Gut; 2020 Feb; 69(2):365-379. PubMed ID: 31076403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Accumulation of myeloid-derived suppressor cells in the spleen and peripheral blood of Schistosoma japonicum-infected mice].
    Pan W; Shen YJ; Liu H; Hu Y; Jiang YY; Zhou HJ; Xu YX; Yuan ZY; Wang YJ; Cao JP
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Feb; 32(1):6-11. PubMed ID: 24822356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-17A deficiency ameliorates streptozotocin-induced diabetes.
    Tong Z; Liu W; Yan H; Dong C
    Immunology; 2015 Oct; 146(2):339-46. PubMed ID: 26211676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and prognostic significance of CD14 (+) HLA-DR (-/low) myeloid-derived suppressor cells in patients with hepatocellular carcinoma received transarterial radioembolization with Yttrium-90.
    Boral B; Ballı HT; Sözütok S; Pehlivan UA; Aikimbaev K
    Scand J Immunol; 2022 Mar; 95(3):e13132. PubMed ID: 34936119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immune function of myeloid-derived suppressor cells and its mechanism in obstructive sleep apnea syndrome].
    Chen SW; Li J; Xiang B; Xu SJ; Wang L
    Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(4):295-300. PubMed ID: 32075359
    [No Abstract]   [Full Text] [Related]  

  • 46. Increased circulating Lin(-/low) CD33(+) HLA-DR(-) myeloid-derived suppressor cells in hepatocellular carcinoma patients.
    Shen P; Wang A; He M; Wang Q; Zheng S
    Hepatol Res; 2014 Jun; 44(6):639-50. PubMed ID: 23701406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.
    Hoechst B; Ormandy LA; Ballmaier M; Lehner F; Krüger C; Manns MP; Greten TF; Korangy F
    Gastroenterology; 2008 Jul; 135(1):234-43. PubMed ID: 18485901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer.
    Metzger P; Kirchleitner SV; Kluge M; Koenig LM; Hörth C; Rambuscheck CA; Böhmer D; Ahlfeld J; Kobold S; Friedel CC; Endres S; Schnurr M; Duewell P
    J Immunother Cancer; 2019 Nov; 7(1):288. PubMed ID: 31694706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
    Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
    Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of myeloid-derived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinoma.
    Lacotte S; Slits F; Orci LA; Meyer J; Oldani G; Delaune V; Gonelle-Gispert C; Morel P; Toso C
    Oncoimmunology; 2016; 5(11):e1234565. PubMed ID: 27999748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs.
    Bosiljcic M; Cederberg RA; Hamilton MJ; LePard NE; Harbourne BT; Collier JL; Halvorsen EC; Shi R; Franks SE; Kim AY; Banáth JP; Hamer M; Rossi FM; Bennewith KL
    Breast Cancer Res; 2019 Sep; 21(1):103. PubMed ID: 31488209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma.
    Weber R; Riester Z; Hüser L; Sticht C; Siebenmorgen A; Groth C; Hu X; Altevogt P; Utikal JS; Umansky V
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32788238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Xuanhusuo powder has an anti-breast cancer effect by inhibiting myeloid-derived suppressor cell differentiation in the spleen of mice through down-regulating granulocyte colony stimulating factor.
    Mao Y; Liu X; He K; Lin C; He B; Gao J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 52(1):88-100. PubMed ID: 37283122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation of myeloid derived suppressor cells (MDSC) from naive and pancreatic tumor-bearing mice using flow cytometry and automated magnetic activated cell sorting (AutoMACS).
    Nelson N; Szekeres K; Cooper D; Ghansah T
    J Vis Exp; 2012 Jun; (64):e3875. PubMed ID: 22733203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment.
    Zhang F; Hu K; Liu W; Quan B; Li M; Lu S; Chen R; Ren Z; Yin X
    Cell Mol Gastroenterol Hepatol; 2023; 15(3):573-591. PubMed ID: 36513250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-tumor immune response of folate-conjugated chitosan nanoparticles containing the IP-10 gene in mice with hepatocellular carcinoma.
    Lai C; Yu X; Zhuo H; Zhou N; Xie Y; He J; Peng Y; Xie X; Luo G; Zhou S; Zhao Y; Lu X
    J Biomed Nanotechnol; 2014 Dec; 10(12):3576-89. PubMed ID: 26000371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Hypertonic Saline and Hydroxyethyl Starch on Myeloid-Derived Suppressor Cells in Hemorrhagic Shock Mice under Secondary Bacterial Attack.
    Jiang JK; Hong LJ; Lu YQ
    Biomed Res Int; 2020; 2020():5417201. PubMed ID: 32258126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stem cell factor produced by tumor cells expands myeloid-derived suppressor cells in mice.
    Lee WC; Hsu PY; Hsu HY
    Sci Rep; 2020 Jul; 10(1):11257. PubMed ID: 32647215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice.
    Zoglmeier C; Bauer H; Noerenberg D; Wedekind G; Bittner P; Sandholzer N; Rapp M; Anz D; Endres S; Bourquin C
    Clin Cancer Res; 2011 Apr; 17(7):1765-75. PubMed ID: 21233400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of a whole blood assay for quantifying myeloid-derived suppressor cells.
    Apodaca MC; Wright AE; Riggins AM; Harris WP; Yeung RS; Yu L; Morishima C
    J Immunother Cancer; 2019 Aug; 7(1):230. PubMed ID: 31462270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.